IGF-1, IGF-II, 'free' IGF-I and IGF-binding proteins-2 to -6 during high-dose oestrogen treatment in constitutionally tall girls

European Journal of Endocrinology

Volumn 146, Issue 6, 2002, Pages 823-829

  Rooman, Raoul P A ^a   De Beeck, Lieve Op ^a   Martin, Manou ^a   Van Doorn, Jaap ^a   Mohan, Subburaman ^a   Du Caju, Marc V L ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ETHINYLESTRADIOL; LIGAND; MEDROXYPROGESTERONE ACETATE; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN BINDING PROTEIN 6; SOMATOMEDIN C;

ADOLESCENT; ARTICLE; BLOOD SAMPLING; BODY HEIGHT; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG MEGADOSE; DRUG WITHDRAWAL; ESTROGEN THERAPY; FEMALE; GENDER; HUMAN; IMMUNOASSAY; IMMUNOMODULATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN GLYCOSYLATION; PROTEIN INDUCTION; PROTEIN SYNTHESIS; SCHOOL CHILD; TALL STATURE; TIME; WESTERN BLOTTING; BODY CONSTITUTION; CHILD; DRUG EFFECT; LONGITUDINAL STUDY; METABOLISM;

ADOLESCENT; BODY CONSTITUTION; BODY HEIGHT; CHILD; ESTROGENS; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 4; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 5; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 6; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; LONGITUDINAL STUDIES;

EID: 0036018925     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1460823     Document Type: Article

References (55)

1. Somatomedin-C levels in children and adolescents with gonadal dysgenesis: Differences from age-matched normal females and effect of chronic estrogen replacement therapy
2. Serum levels of insulin-like growth factor (IGF) and IGF binding protein in constitutionally tall children and adolescents
3. Estrogen treatment of tall girls: Dose dependency of effects on subsequent growth and IGF-I levels in blood
4. Hormonal changes during the first year of oestrogen treatment in constitutionally tall girls
5. Suppression of plasma insulin-like growth factor-1 levels in healthy, nulliparous, young women using low dose oral contraceptives
6. Modification of plasma insulin-like growth factors and binding proteins during oral contraceptive use and the normal menstrual cycle
7. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women
8. Progestins abrogate estrogen-induced changes in the insulin-like growth factor axis
9. Effects of different oral oestrogen formulations on insulin-like growth factor-I, growth hormone and growth hormone binding protein in post-menopausal women
10. The route of estrogen replacement therapy confers divergent effects on substrate oxidation and body composition in postmenopausal women
11. Regulation of growth hormone and somatomedin-C secretion in postmenopausal women: Effect of physiological estrogen replacement
12. Changes in serum somatomedin and growth hormone concentrations after 3 weeks oestrogen substitution in post-menopausal women; A pilot study
13. Effects of oral and transdermal oestrogen replacement therapy on plasma levels of insulin-like growth factors and IGF binding proteins 1 and 3: A cross-over study
14. Growth hormone and somatomedin C during post-menopausal replacement therapy with oestrogen alone and in combination with an antioestrogen
15. Estrogens exert route- and dose-dependent effects on insulin-like growth factor (IGF)-binding protein-3 and acid-labile subunit of the IGF ternary complex
16. Acute and chronic estrogen effects upon serum somatomedin activity, growth hormone, and prolactin in man
17. Estradiol treatment of acromegaly. Reduction of immunoreactive somatomedin-C and improvement in metabolic status
18. The effect of sex steroids on radioimmunoassayable plasma somatomedin C concentrations
19. Effects of estradiol and exogenous insulin-like growth factor I (IGF-I) on the IGF-I axis during growth hormone inhibition and antagonism
20. Estrogenic inhibition of growth hormone-induced tibial epiphyseal growth in hypophysectomized rats
21. Prolonged oestrogen treatment inhibits growth hormone-induced growth in hypopituitary dwarf mice
22. Insulin-like growth factors and their binding proteins: Biological actions
23. Insulin-like growth factor-binding proteins in serum and other biological fluids: Regulation and functions
24. Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics
25. Effects of oral versus transdermal estrogen on the growth hormone/insulin-like growth factor I axis in younger and older postmenopausal women: A clinical research center study
26. Cross sectional stature and weight reference curves for the UK, 1990
27. Tables for predicting adult height from skeletal age: Revised for use with the Greulich-Pyle hand standards
28. Body mass index reference curves for the UK, 1990
29. Inhibition of access of bound somatomedin to membrane receptor and immunobinding sites: A comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol-extracted serum
30. Twenty-four-hour plasma growth hormone (GH) profiles, urinary GH excretion, and plasma insulin-like growth factor-I and -II levels in prepubertal children with chronic renal insufficiency and severe growth retardation
31. Recombinant synthesis of insulin-like growth factor-binding protein-4 (IGFBP-4): Development, validation, and application of a radio-immunoassay for IGFBP-4 in human serum and other biological fluids
32. Development, validation, and application of a radioimmunoassay for insulin-like growth factor binding protein-5 in human serum and other biological fluids
33. Circulating levels of human insulin-like growth factor binding protein-6 (IGFBP-6) in health and disease as determined by radioimmunoassay
34. Detection of serum insulin-like growth factor binding proteins on Western ligand blots by biotinylated IGF and enhanced chemiluminescence
35. Differential regulation of the growth hormone receptor gene: Effects of dexamethasone and estradiol
36. Bioactivity of a 29-kilodalton insulin-like growth factor binding protein-3 fragment present in excess in chronic renal failure serum
37. Characterization of human insulin-like growth factor-binding proteins by two-dimensional polyacrylamide gel electrophoresis and Western ligand blot analysis
38. Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone
39. Multiple endocrine abnormalities of the growth hormone and insulin-like growth factor axis in prepubertal children with exogenous obesity: Effect of short- and long-term weight reduction
40. Insulin-like growth factors (IGF-I, free IGF-I and IGF-II) and insulin-like growth factor binding proteins (IGFBP-2, IGFBP-3, IGFBP-6, and ALS) in blood circulation
41. Potential mechanism of estrogen-mediated decrease in bone formation: Estrogen increases production of inhibitory insulin-like growth factor-binding protein-4
42. Transcriptional activation of insulin-like growth factor-binding protein-4 by 17β-estradiol in MCF-7 cells: Role of estrogen receptor-Sp1 complexes
43. Effects of recombinant insulin-like growth factor-binding protein-4 on bone formation parameters in mice
44. A protease-resistant form of insulin-like growth factor (IGF) binding protein 4 inhibits IGF-1 actions
45. Studies on the potential mediators of skeletal changes occurring during puberty in girls
46. Radioimmunoassay of insulin-like growth factor-binding protein-6 in human serum and other body fluids
47. Effect of menopause and different combined estradiol-progestin regimens on basal and growth hormone-releasing hormone-stimulated serum growth hormone, insulin-like growth factor-1, insulin-like growth factor binding (IGFBP)-1, and IGFBP-3 levels
48. Differential effects of estrogen and growth hormone on uterine and hepatic insulin-like growth factor I gene expression in the ovariectomized hypophysectomized rat
49. Regulation of somatic growth and the somatotropic axis by gonadal steroids: Primary effect on insulin-like growth factor I gene expression and secretion
50. Estrogen action on hepatic synthesis of angiotensinogen and IGF-I: Direct and indirect estrogen effects
51. Estrogen receptor (ER)-alpha, but not ER-beta, mediates regulation of the insulin-like growth factor I gene by anti-estrogens
52. Editorial review: The case of local versus endocrine IGF-I actions: The jury is still out
53. The estrogen receptor in the growth plate: Implications for pubertal growth
54. Oral estrogen antagonizes the metabolic actions of growth hormone in growth hormone-deficient women